Chemokine receptors CCR6 and CXCR3 are necessary for CD4(+) T cell mediated ocular surface disease in experimental dry eye disease.
about
Managing Sjögren's Syndrome and non-Sjögren Syndrome dry eye with anti-inflammatory therapy.Desiccating stress-induced chemokine expression in the epithelium is dependent on upregulation of NKG2D/RAE-1 and release of IFN-γ in experimental dry eye.Age-related Defects in Ocular and Nasal Mucosal Immune System and the Immunopathology of Dry Eye DiseaseMacrophage Phenotype in the Ocular Surface of Experimental Murine Dry Eye Disease.Improvement of Outcome Measures of Dry Eye by a Novel Integrin Antagonist in the Murine Desiccating Stress Model.Age-Related Conjunctival Disease in the C57BL/6.NOD-Aec1Aec2 Mouse Model of Sjögren Syndrome Develops Independent of Lacrimal Dysfunction.Tissue resident memory T cells in the human conjunctiva and immune signatures in human dry eye disease.Age-related spontaneous lacrimal keratoconjunctivitis is accompanied by dysfunctional T regulatory cells.Langerhans cells prevent subbasal nerve damage and upregulate neurotrophic factors in dry eye disease.Ageing and ocular surface immunity.Mucosal immune tolerance at the ocular surface in health and disease.TRI Microspheres prevent key signs of dry eye disease in a murine, inflammatory model.The Pathophysiology of Dry Eye Disease: What We Know and Future Directions for Research.IFN-γ-Expressing Th17 Cells Are Required for Development of Severe Ocular Surface Autoimmunity.Sjögren-Like Lacrimal Keratoconjunctivitis in Germ-Free Mice.Association of the polymorphisms of chemokine genes (IL8, RANTES, MIG, IP10, MCP1 and IL16) with the pathogenesis of autoimmune thyroid diseases.Effects of Aging in Dry Eye.Once-Daily Cyclosporine-A-MiDROPS for Treatment of Dry Eye DiseaseInnate and Adaptive Cell Populations Driving Inflammation in Dry Eye Disease
P2860
Q34028408-37F23625-E190-4612-8786-68C6B907258CQ34476263-01E196CA-6F57-4B80-A03C-79E51835AAABQ35773063-78388CCE-5E39-4948-BB6D-C3FA58AAFC26Q35911918-C53FA302-69C7-4D7D-8066-6DA1BD8A35C0Q36050556-3DDCE9E4-24B9-4F19-8B4F-BA33127EEB50Q36395133-93141599-7167-453A-ADAC-E72AB9AB187EQ37721598-B99F5982-FAE5-4D18-8616-6A6250BD6695Q37737497-8E986834-CE94-454A-AA5E-F22F82733AF4Q38820726-69EACAA0-959F-4375-887C-2028E144EF56Q38886086-FBE8BD64-EA17-4FD2-B3BC-5097D8A39EEEQ39097223-C7B5A92E-CB52-44CD-9B71-1D8B16D96980Q47138569-47073CF7-0EF5-4833-9AB3-2BB4E1C2DBB3Q47884949-1296A622-3ED1-44DE-8DE0-00F7FF42E296Q48240995-57A501DC-3E55-46E4-9FA6-6E9AA5D4DCDAQ50041932-1D6870DB-CBF9-413C-8060-40BD6BC82CABQ51728143-1D9DE59A-8497-43C3-9AFC-F71C14CC58A6Q51836466-9508298E-1BA7-46ED-94E5-DAB37AFF5DD9Q57479273-1485652A-33F5-4676-BD0E-CA1B86099840Q58787880-513E23E2-DF44-4A3E-9A70-68E709FF54DF
P2860
Chemokine receptors CCR6 and CXCR3 are necessary for CD4(+) T cell mediated ocular surface disease in experimental dry eye disease.
description
2013 nî lūn-bûn
@nan
2013 թուականի Նոյեմբերին հրատարակուած գիտական յօդուած
@hyw
2013 թվականի նոյեմբերին հրատարակված գիտական հոդված
@hy
2013年の論文
@ja
2013年論文
@yue
2013年論文
@zh-hant
2013年論文
@zh-hk
2013年論文
@zh-mo
2013年論文
@zh-tw
2013年论文
@wuu
name
Chemokine receptors CCR6 and C ...... experimental dry eye disease.
@ast
Chemokine receptors CCR6 and C ...... experimental dry eye disease.
@en
type
label
Chemokine receptors CCR6 and C ...... experimental dry eye disease.
@ast
Chemokine receptors CCR6 and C ...... experimental dry eye disease.
@en
prefLabel
Chemokine receptors CCR6 and C ...... experimental dry eye disease.
@ast
Chemokine receptors CCR6 and C ...... experimental dry eye disease.
@en
P2093
P2860
P1433
P1476
Chemokine receptors CCR6 and C ...... experimental dry eye disease.
@en
P2093
Eugene A Volpe
Niral B Gandhi
Stephen C Pflugfelder
Terry G Coursey
P2860
P304
P356
10.1371/JOURNAL.PONE.0078508
P407
P577
2013-11-04T00:00:00Z